ViBA

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight.

Gupta J, Malik MZ, Chaturvedi M · Virusdisease · 2023 · Article

10.1007/s13337-023-00820-3

Verified evidence

Bibliographic record.